138 related articles for article (PubMed ID: 20078385)
1. CD34(+) cell selection using small-volume marrow aspirates: a platform for novel cell therapies and regenerative medicine.
McKenna DH; Adams S; Sumstad D; Sumstad T; Kadidlo D; Gee AP; Durett A; Griffin D; Donnenberg A; Amrani D; Livingston D; Lindblad R; Wood D; Styers D
Cytotherapy; 2010 Apr; 12(2):170-7. PubMed ID: 20078385
[TBL] [Abstract][Full Text] [Related]
2. T-cell depletion of allogeneic bone marrow grafts: enrichment of mononuclear cells using the COBE Spectra cell processor, followed by immunoselection of CD34(+) cells.
Olivero S; Novakovitch G; Ladaique P; Sainty D; Viret F; Faucher C; Stoppa AM; Blaise D; Chabannon C
Cytotherapy; 1999; 1(6):469-77. PubMed ID: 20443236
[TBL] [Abstract][Full Text] [Related]
3. Intra-operative preparation of autologous bone marrow-derived CD34-enriched cellular products for cardiac therapy.
Donnenberg AD; Donnenberg VS; Griffin DL; Moore LR; Tekinturhan F; Kormos RL
Cytotherapy; 2011 Apr; 13(4):441-8. PubMed ID: 21062114
[TBL] [Abstract][Full Text] [Related]
4. CD34 selection using three immunoselection devices: comparison of T-cell depleted allografts.
O'Donnell PV; Myers B; Edwards J; Loper K; Rhubart P; Noga SJ
Cytotherapy; 2001; 3(6):483-8. PubMed ID: 11953032
[TBL] [Abstract][Full Text] [Related]
5. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
6. Combined positive and negative cell selection from allogeneic peripheral blood progenitor cells (PBPC) by use of immunomagnetic methods.
Martín-Henao GA; Picón M; Amill B; Querol S; Ferrà C; Grañena A; García J
Bone Marrow Transplant; 2001 Apr; 27(7):683-7. PubMed ID: 11360106
[TBL] [Abstract][Full Text] [Related]
7. Human bone marrow processing using a new continuous-flow cell separation device.
Guttridge MG; Bailey C; Sidders C; Nichols J; Bromham J; Watt SM
Transfusion; 2016 Apr; 56(4):899-904. PubMed ID: 26662223
[TBL] [Abstract][Full Text] [Related]
8. CD34+ cell selection in chronic phase chronic myeloid leukaemia: a comparison of laboratory grade columns.
Hawkins TE; Marley SB; O'Brien SG; Gordon MY; Goldman JM
Bone Marrow Transplant; 1997 Sep; 20(5):409-13. PubMed ID: 9339758
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of the original content of CD34(+) cells for enrichment of hematopoietic progenitor cells from bone marrow harvests by the apheresis procedure.
Itoh T; Minegishi M; Kudo Y; Saito N; Takahashi H; Suzuki A; Narita A; Sato Y; Miura J; Inoue Y; Kameoka J; Suwabe N; Imaizumi M; Okuda M; Tsuchiya S
J Clin Apher; 2006 Oct; 21(3):176-80. PubMed ID: 16619225
[TBL] [Abstract][Full Text] [Related]
10. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR
Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
[TBL] [Abstract][Full Text] [Related]
11. Purging and haemopoietic progenitor cell selection by CD34+ cell separation.
Krüger W; Gruber M; Hennings S; Fehse N; Fehse B; Gutensohn K; Kröger N; Zander AR
Bone Marrow Transplant; 1998 Apr; 21(7):665-71. PubMed ID: 9578305
[TBL] [Abstract][Full Text] [Related]
12. Comparison of single- and dual-platform approaches to enumerate CD34(+) cells in bone marrow and mobilized peripheral blood stem cells.
Piedras-Ross J; León-Rodríguez E; Sánchez-Guerrero S; López-Karpovitch X
Arch Med Res; 2003; 34(1):16-9. PubMed ID: 12604369
[TBL] [Abstract][Full Text] [Related]
13. Isolex 300i CD34-selected cells to support multiple cycles of high-dose therapy.
Prince HM; Bashford J; Wall D; Rischin D; Parker N; Toner GC; Seymour JF; Blakey D; Haylock D; Simmons P; Francis P; Wolf M; Januszewicz EH; Richardson G; Scarlett J; Briggs P
Cytotherapy; 2002; 4(2):137-45. PubMed ID: 12006209
[TBL] [Abstract][Full Text] [Related]
14. A controlled comparison of two different clinical grade devices for CD34+ cell selection of autologous blood stem cell grafts.
Björkstrand B; Sundman-Engberg B; Christensson B; Kumlien G
J Hematother; 1999 Feb; 8(1):75-80. PubMed ID: 10192304
[TBL] [Abstract][Full Text] [Related]
15. Impact on T-cell depletion and CD34+ cell recovery using humanised CD52 monoclonal antibody (CAMPATH-1H) in BM and PSBC collections; comparison with CAMPATH-1M and CAMPATH-1G.
Williams RJ; Clarke E; Blair A; Evely R; Hale G; Waldmann H; Brookes S; Pamphilon DH
Cytotherapy; 2000; 2(1):5-14. PubMed ID: 12042050
[TBL] [Abstract][Full Text] [Related]
16. Comparison of CD34+ bone marrow cells purified by immunomagnetic and immunoadsorption cell separation techniques.
Firat H; Giarratana MC; Kobari L; Poloni A; Bouchet S; Labopin M; Gorin NC; Douay L
Bone Marrow Transplant; 1998 May; 21(9):933-8. PubMed ID: 9613787
[TBL] [Abstract][Full Text] [Related]
17. Delineation of cell cycle state and correlation to adhesion molecule expression of human CD34+ cells from steady-state bone marrow and peripheral blood mobilized following G-CSF-supported chemotherapy.
Fruehauf S; Veldwijk MR; Krämer A; Haas R; Zeller WJ
Stem Cells; 1998; 16(4):271-9. PubMed ID: 9708449
[TBL] [Abstract][Full Text] [Related]
18. Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS (v2.1) and Isolex 300i (v2.5) clinical scale devices.
Watts MJ; Somervaille TC; Ings SJ; Ahmed F; Khwaja A; Yong K; Linch DC
Br J Haematol; 2002 Jul; 118(1):117-23. PubMed ID: 12100134
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow processing for transplantation using Cobe Spectra cell separator.
Veljković D; Nonković OŠ; Radonjić Z; Kuzmanović M; Zečević Z
Transfus Apher Sci; 2013 Jun; 48(3):359-63. PubMed ID: 23628356
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Haemonetics Cell Saver 5+ and manual density separation for optimum depletion of red blood cells and preservation of CD34
Qudeimat A; Zandaki D; Bi Y; Li Y; Davis K; Alloush L; Selukar S; Triplett B; Akel S; Srinivasan A
Cytotherapy; 2023 Nov; 25(11):1145-1148. PubMed ID: 37598335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
